# Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma

> **NCT03604328** · PHASE1 · COMPLETED · sponsor: **PolyActiva Pty Ltd** · enrollment: 8 (actual)

## Conditions studied

- Open-angle Glaucoma

## Interventions

- **DRUG:** PA5108

## Key facts

- **NCT ID:** NCT03604328
- **Lead sponsor:** PolyActiva Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-24
- **Primary completion:** 2020-06-15
- **Final completion:** 2020-06-15
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03604328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03604328, "Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03604328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*